Acebutolol
Hydralazine may increase the hypotensive activities of Acebutolol.
Aceclofenac
Aceclofenac may decrease the antihypertensive activities of Hydralazine.
Acemetacin
The therapeutic efficacy of Hydralazine can be decreased when used in combination with Acemetacin.
Advertisement
Acetyl salicylate
Acetylsalicylic acid may decrease the antihypertensive activities of Hydralazine.
Adapalene
Adapalene may decrease the antihypertensive activities of Hydralazine.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydralazine.
Advertisement
Alfuzosin
Alfuzosin may increase the hypotensive activities of Hydralazine.
Aliskiren
Hydralazine may increase the hypotensive activities of Aliskiren.
Alminoprofen
Alminoprofen may decrease the antihypertensive activities of Hydralazine.
Advertisement
Alprenolol
Hydralazine may increase the hypotensive activities of Alprenolol.
Ambrisentan
Hydralazine may increase the hypotensive activities of Ambrisentan.
Amifostine
Hydralazine may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Hydralazine may increase the hypotensive activities of Amifostine.
Amiloride
The risk or severity of adverse effects can be increased when Amiloride is combined with Hydralazine.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Hydralazine.
Amlodipine
Hydralazine may increase the hypotensive activities of Amlodipine.
Amobarbital
Amobarbital may increase the hypotensive activities of Hydralazine.
Amphetamine
Amphetamine may increase the hypotensive activities of Hydralazine.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Hydralazine.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Hydralazine.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Hydralazine is combined with Amyl Nitrite.
Antipyrine
Antipyrine may decrease the antihypertensive activities of Hydralazine.
Apazone
Azapropazone may decrease the antihypertensive activities of Hydralazine.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Hydralazine.
Apraclonidine
The risk or severity of adverse effects can be increased when Apraclonidine is combined with Hydralazine.
Apremilast
Apremilast may decrease the antihypertensive activities of Hydralazine.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Hydralazine.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Hydralazine.
Aspirin
Acetylsalicylic acid may decrease the antihypertensive activities of Hydralazine.
Atenolol
Hydralazine may increase the hypotensive activities of Atenolol.
Atorvastatin
The risk or severity of adverse effects can be increased when Hydralazine is combined with Atorvastatin.
Avanafil
Avanafil may increase the antihypertensive activities of Hydralazine.
Azelastine
Azelastine may decrease the antihypertensive activities of Hydralazine.
Azilsartan
The risk or severity of adverse effects can be increased when Hydralazine is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Hydralazine is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Hydralazine is combined with Azilsartan medoxomil.
Balsalazide
Balsalazide may decrease the antihypertensive activities of Hydralazine.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Hydralazine.
Barbital
Barbital may increase the hypotensive activities of Hydralazine.
Benazepril
Hydralazine may increase the hypotensive activities of Benazepril.
Bendroflumethiazide
Hydralazine may increase the hypotensive activities of Bendroflumethiazide.
Benzydamine
Benzydamine may decrease the antihypertensive activities of Hydralazine.
Bepridil
Hydralazine may increase the hypotensive activities of Bepridil.
Betaxolol
Hydralazine may increase the hypotensive activities of Betaxolol.
Bethanidine
Bethanidine may increase the hypotensive activities of Hydralazine.
Bimatoprost
Hydralazine may increase the hypotensive activities of Bimatoprost.
Bisoprolol
Hydralazine may increase the hypotensive activities of Bisoprolol.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Hydralazine.
Bosentan
Bosentan may increase the hypotensive activities of Hydralazine.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Hydralazine.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Hydralazine.
Bretylium
Hydralazine may increase the hypotensive activities of Bretylium.
Brimonidine
Brimonidine may increase the antihypertensive activities of Hydralazine.
Bromfenac
Bromfenac may decrease the antihypertensive activities of Hydralazine.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Hydralazine.
Bufexamac
Bufexamac may decrease the antihypertensive activities of Hydralazine.
Bumetanide
The risk or severity of adverse effects can be increased when Bumetanide is combined with Hydralazine.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Hydralazine.
Bupranolol
Hydralazine may increase the hypotensive activities of Bupranolol.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Hydralazine.
Cafedrine
Hydralazine may increase the hypotensive activities of Cafedrine.
Canagliflozin
The risk or severity of adverse effects can be increased when Hydralazine is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Hydralazine is combined with Canagliflozin.
Candesartan
Hydralazine may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Hydralazine may increase the hypotensive activities of Candesartan cilexetil.
Captopril
Hydralazine may increase the hypotensive activities of Captopril.
Carprofen
Carprofen may decrease the antihypertensive activities of Hydralazine.
Carteolol
Hydralazine may increase the hypotensive activities of Carteolol.
Carvedilol
Hydralazine may increase the hypotensive activities of Carvedilol.
Celecoxib
Celecoxib may decrease the antihypertensive activities of Hydralazine.
Celiprolol
Hydralazine may increase the hypotensive activities of Celiprolol.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Hydralazine.
Chloroquine
Chloroquine may decrease the antihypertensive activities of Hydralazine.
Chlorothiazide
Hydralazine may increase the hypotensive activities of Chlorothiazide.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Hydralazine.
Chlorthalidone
Hydralazine may increase the hypotensive activities of Chlorthalidone.
Choline Magnesium Trisalicyclate
Choline magnesium trisalicylate may decrease the antihypertensive activities of Hydralazine.
Cicletanine
Hydralazine may increase the hypotensive activities of Cicletanine.
Cilazapril
Hydralazine may increase the hypotensive activities of Cilazapril.
Clevidipine
The risk or severity of adverse effects can be increased when Hydralazine is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Hydralazine is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Hydralazine.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Hydralazine.
Clonidine
Clonidine may increase the hypotensive activities of Hydralazine.
Clonixin
Clonixin may decrease the antihypertensive activities of Hydralazine.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Hydralazine.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Hydralazine.
Cryptenamine
Hydralazine may increase the hypotensive activities of Cryptenamine.
Curcumin
Curcumin may decrease the antihypertensive activities of Hydralazine.
Cyclopenthiazide
Hydralazine may increase the hypotensive activities of Cyclopenthiazide.
Cyclothiazide
Hydralazine may increase the hypotensive activities of Cyclothiazide.
Dapagliflozin
The risk or severity of adverse effects can be increased when Hydralazine is combined with Dapagliflozin.
Debrisoquin
Hydralazine may increase the hypotensive activities of Debrisoquin.
Deserpidine
Hydralazine may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Hydralazine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Hydralazine.
Diazoxide
Diazoxide may increase the hypotensive activities of Hydralazine.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Diclofenamide is combined with Hydralazine.
Diclofenac
Diclofenac may decrease the antihypertensive activities of Hydralazine.
Diflunisal
Diflunisal may decrease the antihypertensive activities of Hydralazine.
Dihydralazine
Hydralazine may increase the hypotensive activities of Dihydralazine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Hydralazine.
Diltiazem
Hydralazine may increase the hypotensive activities of Diltiazem.
Dinutuximab
The risk or severity of adverse effects can be increased when Hydralazine is combined with Dinutuximab.
Dipyridamole
The risk or severity of adverse effects can be increased when Dipyridamole is combined with Hydralazine.
Dipyrone
Metamizole may decrease the antihypertensive activities of Hydralazine.
Dorzolamide
Hydralazine may increase the hypotensive activities of Dorzolamide.
Doxazosin
Doxazosin may increase the hypotensive activities of Hydralazine.
Droxicam
Droxicam may decrease the antihypertensive activities of Hydralazine.
Duloxetine
Hydralazine may increase the orthostatic hypotensive activities of Duloxetine.
Empagliflozin
The risk or severity of adverse effects can be increased when Hydralazine is combined with Empagliflozin.
Enalapril
Hydralazine may increase the hypotensive activities of Enalapril.
Enalaprilat
Hydralazine may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Hydralazine may increase the hypotensive activities of Enalaprilat.
Eplerenone
The risk or severity of adverse effects can be increased when Eplerenone is combined with Hydralazine.
Epoprostenol
Hydralazine may increase the hypotensive activities of Epoprostenol.
Eprosartan
Hydralazine may increase the hypotensive activities of Eprosartan.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Hydralazine.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Hydralazine.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Hydralazine.
Etanercept
Etanercept may decrease the antihypertensive activities of Hydralazine.
Ethacrynate
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Hydralazine.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Hydralazine.
Etodolac
Etodolac may decrease the antihypertensive activities of Hydralazine.
Etofenamate
Etofenamate may decrease the antihypertensive activities of Hydralazine.
Etoricoxib
Etoricoxib may decrease the antihypertensive activities of Hydralazine.
Evening primrose oil
Evening primrose oil may decrease the antihypertensive activities of Hydralazine.
Felbinac
Felbinac may decrease the antihypertensive activities of Hydralazine.
Felodipine
Hydralazine may increase the hypotensive activities of Felodipine.
Fenbufen
Fenbufen may decrease the antihypertensive activities of Hydralazine.
Fenoldopam
Hydralazine may increase the hypotensive activities of Fenoldopam.
Fenoprofen
Fenoprofen may decrease the antihypertensive activities of Hydralazine.
Ferulic Acid
Ferulic acid may decrease the antihypertensive activities of Hydralazine.
Floctafenine
Floctafenine may decrease the antihypertensive activities of Hydralazine.
Flurbiprofen
Flurbiprofen may decrease the antihypertensive activities of Hydralazine.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Hydralazine.
Fosinopril
Hydralazine may increase the hypotensive activities of Fosinopril.
Furazolidone
Furazolidone may increase the hypotensive activities of Hydralazine.
Furosemide
The risk or severity of adverse effects can be increased when Furosemide is combined with Hydralazine.
Guanabenz
Hydralazine may increase the hypotensive activities of Guanabenz.
Guanadrel
Hydralazine may increase the hypotensive activities of Guanadrel.
Guanethidine
Hydralazine may increase the hypotensive activities of Guanethidine.
Guanfacine
Guanfacine may increase the hypotensive activities of Hydralazine.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Hydralazine.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Hydralazine.
Hydrochlorothiazide
Hydralazine may increase the hypotensive activities of Hydrochlorothiazide.
Hydroflumethiazide
Hydralazine may increase the hypotensive activities of Hydroflumethiazide.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Hydralazine.
Ibuprofen
Ibuprofen may decrease the antihypertensive activities of Hydralazine.
Icatibant
Icatibant may decrease the antihypertensive activities of Hydralazine.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Hydralazine.
Imidapril
Hydralazine may increase the hypotensive activities of Imidapril.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Hydralazine.
Indapamide
Hydralazine may increase the hypotensive activities of Indapamide.
Indobufen
Indobufen may decrease the antihypertensive activities of Hydralazine.
Indomethacin
Indomethacin may decrease the antihypertensive activities of Hydralazine.
Indoramin
Hydralazine may increase the hypotensive activities of Indoramin.
Iproniazid
Iproniazid may increase the hypotensive activities of Hydralazine.
Irbesartan
Hydralazine may increase the hypotensive activities of Irbesartan.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Hydralazine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Hydralazine.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Isosorbide Dinitrate is combined with Hydralazine.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Hydralazine.
Isoxsuprine
The risk or severity of adverse effects can be increased when Hydralazine is combined with Isoxsuprine.
Isradipine
Hydralazine may increase the hypotensive activities of Isradipine.
Kebuzone
Kebuzone may decrease the antihypertensive activities of Hydralazine.
Ketanserin
Hydralazine may increase the hypotensive activities of Ketanserin.
Ketoprofen
Ketoprofen may decrease the antihypertensive activities of Hydralazine.
Ketorolac
Ketorolac may decrease the antihypertensive activities of Hydralazine.
Labetalol
Hydralazine may increase the hypotensive activities of Labetalol.
Lacidipine
Hydralazine may increase the hypotensive activities of Lacidipine.
Latanoprost
Hydralazine may increase the hypotensive activities of Latanoprost.
Leflunomide
Leflunomide may decrease the antihypertensive activities of Hydralazine.
Lercanidipine
Hydralazine may increase the hypotensive activities of Lercanidipine.
Levobunolol
The risk or severity of adverse effects can be increased when Levobunolol is combined with Hydralazine.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Hydralazine.
Levodopa
Hydralazine may increase the orthostatic hypotensive activities of Levodopa.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Hydralazine.
Limonene, (+)-
(4R)-limonene may decrease the antihypertensive activities of Hydralazine.
Lisinopril
Hydralazine may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Hydralazine may increase the hypotensive activities of Lisinopril.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Hydralazine.
Lofexidine
Hydralazine may increase the hypotensive activities of Lofexidine.
Lornoxicam
Lornoxicam may decrease the antihypertensive activities of Hydralazine.
Losartan
Hydralazine may increase the hypotensive activities of Losartan.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Hydralazine.
Loxoprofen
Loxoprofen may decrease the antihypertensive activities of Hydralazine.
Macitentan
Hydralazine may increase the hypotensive activities of Macitentan.
Magnesium Salicylate
Magnesium salicylate may decrease the antihypertensive activities of Hydralazine.
Manidipine
Hydralazine may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Mannitol is combined with Hydralazine.
Masoprocol
Masoprocol may decrease the antihypertensive activities of Hydralazine.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Hydralazine.
Meclofenamate
Meclofenamic acid may decrease the antihypertensive activities of Hydralazine.
Meclofenamic Acid
Meclofenamic acid may decrease the antihypertensive activities of Hydralazine.
Mefenamic Acid
Mefenamic acid may decrease the antihypertensive activities of Hydralazine.
Meloxicam
Meloxicam may decrease the antihypertensive activities of Hydralazine.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Hydralazine.
Mepirodipine
Hydralazine may increase the antihypertensive activities of Barnidipine.
Mesalamine
Mesalazine may decrease the antihypertensive activities of Hydralazine.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Hydralazine.
Methazolamide
The risk or severity of adverse effects can be increased when Methazolamide is combined with Hydralazine.
Methohexital
Methohexital may increase the hypotensive activities of Hydralazine.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Hydralazine.
Methyldopa
Hydralazine may increase the hypotensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Hydralazine may increase the hypotensive activities of Methyldopa.
Methylene blue
Methylene blue may increase the hypotensive activities of Hydralazine.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Hydralazine.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Hydralazine.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Hydralazine.
Metipranolol
Hydralazine may increase the hypotensive activities of Metipranolol.
Metolazone
Hydralazine may increase the hypotensive activities of Metolazone.
Metoprolol
Hydralazine may increase the hypotensive activities of Metoprolol.
Metyrosine
Hydralazine may increase the hypotensive activities of Metyrosine.
Mibefradil
Hydralazine may increase the hypotensive activities of Mibefradil.
Minaprine
Minaprine may increase the hypotensive activities of Hydralazine.
Minoxidil
Minoxidil may increase the hypotensive activities of Hydralazine.
Moclobemide
Moclobemide may increase the hypotensive activities of Hydralazine.
Moexipril
Hydralazine may increase the hypotensive activities of Moexipril.
Molsidomine
Molsidomine may increase the hypotensive activities of Hydralazine.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Hydralazine.
Moxonidine
Hydralazine may increase the hypotensive activities of Moxonidine.
MYCOPHENOLATE
Mycophenolic acid may decrease the antihypertensive activities of Hydralazine.
Mycophenolate Mofetil
Mycophenolate mofetil may decrease the antihypertensive activities of Hydralazine.
Mycophenolic Acid
Mycophenolic acid may decrease the antihypertensive activities of Hydralazine.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Hydralazine.
Nabumetone
Nabumetone may decrease the antihypertensive activities of Hydralazine.
Nadolol
Hydralazine may increase the hypotensive activities of Nadolol.
Naftifine
Naftifine may decrease the antihypertensive activities of Hydralazine.
Naproxen
Naproxen may decrease the antihypertensive activities of Hydralazine.
Nebivolol
Hydralazine may increase the hypotensive activities of Nebivolol.
Nepafenac
Nepafenac may decrease the antihypertensive activities of Hydralazine.
Nesiritide
The risk or severity of adverse effects can be increased when Hydralazine is combined with Nesiritide.
Nialamide
Nialamide may increase the hypotensive activities of Hydralazine.
Nicardipine
Hydralazine may increase the hypotensive activities of Nicardipine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Hydralazine.
Nicorandil
Nicorandil may increase the hypotensive activities of Hydralazine.
Nifedipine
The risk or severity of adverse effects can be increased when Nifedipine is combined with Hydralazine.
Niflumic Acid
Niflumic Acid may decrease the antihypertensive activities of Hydralazine.
Nilvadipine
Hydralazine may increase the hypotensive activities of Nilvadipine.
Nimesulide
Nimesulide may decrease the antihypertensive activities of Hydralazine.
Nimodipine
Hydralazine may increase the hypotensive activities of Nimodipine.
Nisoldipine
Hydralazine may increase the hypotensive activities of Nisoldipine.
Nitrendipine
Hydralazine may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Hydralazine.
Nitroglycerin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Hydralazine.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Hydralazine.
Obinutuzumab
Hydralazine may increase the hypotensive activities of Obinutuzumab.
Oenothera biennis seed extract
Evening primrose oil may decrease the antihypertensive activities of Hydralazine.
Olmesartan
Hydralazine may increase the hypotensive activities of Olmesartan.
Olopatadine
Olopatadine may decrease the antihypertensive activities of Hydralazine.
Olsalazine
Olsalazine may decrease the antihypertensive activities of Hydralazine.
Oxaprozin
Oxaprozin may decrease the antihypertensive activities of Hydralazine.
Oxprenolol
Hydralazine may increase the hypotensive activities of Oxprenolol.
Oxyphenbutazone
Oxyphenbutazone may decrease the antihypertensive activities of Hydralazine.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Hydralazine.
Papaverine
The risk or severity of adverse effects can be increased when Papaverine is combined with Hydralazine.
Parecoxib
Parecoxib may decrease the antihypertensive activities of Hydralazine.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Hydralazine.
Pargyline
Pargyline may increase the hypotensive activities of Hydralazine.
Parthenolide
Parthenolide may decrease the antihypertensive activities of Hydralazine.
Penbutolol
Hydralazine may increase the hypotensive activities of Penbutolol.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Hydralazine.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Hydralazine.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Hydralazine.
Perindopril
Hydralazine may increase the hypotensive activities of Perindopril.
Phenelzine
Phenelzine may increase the hypotensive activities of Hydralazine.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Hydralazine.
Phenoxybenzamine
Hydralazine may increase the hypotensive activities of Phenoxybenzamine.
Phentolamine
Hydralazine may increase the hypotensive activities of Phentolamine.
Phentolamine Mesylate
Hydralazine may increase the hypotensive activities of Phentolamine.
Phenylbutazone
Phenylbutazone may decrease the antihypertensive activities of Hydralazine.
Pimecrolimus
Pimecrolimus may decrease the antihypertensive activities of Hydralazine.
Pinacidil
Hydralazine may increase the hypotensive activities of Pinacidil.
Pindolol
Hydralazine may increase the hypotensive activities of Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Hydralazine.
Pirfenidone
Pirfenidone may decrease the antihypertensive activities of Hydralazine.
Piroxicam
Piroxicam may decrease the antihypertensive activities of Hydralazine.
Piroxicam-Beta-Cyclodextrin
Piroxicam may decrease the antihypertensive activities of Hydralazine.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Hydralazine.
Polythiazide
Hydralazine may increase the hypotensive activities of Polythiazide.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Hydralazine.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Hydralazine.
Prazosin
Prazosin may increase the hypotensive activities of Hydralazine.
Primidone
Primidone may increase the hypotensive activities of Hydralazine.
Procarbazine
Procarbazine may increase the hypotensive activities of Hydralazine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Hydralazine.
Propranolol
Hydralazine may increase the hypotensive activities of Propranolol.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Hydralazine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Hydralazine.
Quinapril
Hydralazine may increase the hypotensive activities of Quinapril.
Quinine
Quinine may increase the hypotensive activities of Hydralazine.
Ramipril
Hydralazine may increase the hypotensive activities of Ramipril.
Rasagiline
Rasagiline may increase the hypotensive activities of Hydralazine.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Hydralazine.
Rescinnamine
Hydralazine may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Hydralazine.
Resveratrol
Resveratrol may decrease the antihypertensive activities of Hydralazine.
Rilmenidine
Hydralazine may increase the hypotensive activities of Rilmenidine.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Hydralazine.
Riociguat
Hydralazine may increase the hypotensive activities of Riociguat.
Risperidone
Hydralazine may increase the hypotensive activities of Risperidone.
Rituximab
Hydralazine may increase the hypotensive activities of Rituximab.
Rofecoxib
Rofecoxib may decrease the antihypertensive activities of Hydralazine.
Ropinirole
The risk or severity of adverse effects can be increased when Ropinirole is combined with Hydralazine.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Hydralazine.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Hydralazine.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Hydralazine.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Hydralazine.
Salicylamide
Salicylamide may decrease the antihypertensive activities of Hydralazine.
Salicylic Acid
Salicylic acid may decrease the antihypertensive activities of Hydralazine.
Salsalate
Salsalate may decrease the antihypertensive activities of Hydralazine.
Secobarbital
Secobarbital may increase the hypotensive activities of Hydralazine.
Selegiline
Selegiline may increase the hypotensive activities of Hydralazine.
Selexipag
Hydralazine may increase the hypotensive activities of Selexipag.
Serratiopeptidase
Serrapeptase may decrease the antihypertensive activities of Hydralazine.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Hydralazine.
Sildenafil
Sildenafil may increase the antihypertensive activities of Hydralazine.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Hydralazine.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Hydralazine.
Spirapril
Hydralazine may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Hydralazine.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Hydralazine.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Hydralazine.
Sulfasalazine
Sulfasalazine may decrease the antihypertensive activities of Hydralazine.
Sulindac
Sulindac may decrease the antihypertensive activities of Hydralazine.
Suprofen
Suprofen may decrease the antihypertensive activities of Hydralazine.
Tadalafil
Tadalafil may increase the antihypertensive activities of Hydralazine.
Talinolol
Hydralazine may increase the hypotensive activities of Talinolol.
Tamsulosin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Hydralazine.
Telmisartan
Hydralazine may increase the hypotensive activities of Telmisartan.
Tenoxicam
Tenoxicam may decrease the antihypertensive activities of Hydralazine.
Terazosin
The risk or severity of adverse effects can be increased when Terazosin is combined with Hydralazine.
Teriflunomide
Teriflunomide may decrease the antihypertensive activities of Hydralazine.
Terlipressin
Hydralazine may increase the hypotensive activities of Terlipressin.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Hydralazine.
Theodrenaline
Hydralazine may increase the hypotensive activities of Theodrenaline.
Thiamylal
Thiamylal may increase the hypotensive activities of Hydralazine.
Thiopental
Thiopental may increase the hypotensive activities of Hydralazine.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Hydralazine.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Hydralazine.
Tiaprofenic Acid
Tiaprofenic acid may decrease the antihypertensive activities of Hydralazine.
Tibolone
Hydralazine may increase the hypotensive activities of Tibolone.
Timolol
Hydralazine may increase the hypotensive activities of Timolol.
Timolol Anhydrous
Hydralazine may increase the hypotensive activities of Timolol.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Hydralazine.
Tolazoline
Hydralazine may increase the hypotensive activities of Tolazoline.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Hydralazine.
Tolfenamic Acid
Tolfenamic Acid may decrease the antihypertensive activities of Hydralazine.
Tolmetin
Tolmetin may decrease the antihypertensive activities of Hydralazine.
Toloxatone
Toloxatone may increase the hypotensive activities of Hydralazine.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Hydralazine.
Torsemide
Hydralazine may increase the hypotensive activities of Torasemide.
Trandolapril
Hydralazine may increase the hypotensive activities of Trandolapril.
Tranilast
Tranilast may decrease the antihypertensive activities of Hydralazine.
Tranylcypromine
Tranylcypromine may increase the hypotensive activities of Hydralazine.
Travoprost
Hydralazine may increase the hypotensive activities of Travoprost.
Treprostinil
Hydralazine may increase the hypotensive activities of Treprostinil.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Hydralazine.
Triamterene
The risk or severity of adverse effects can be increased when Triamterene is combined with Hydralazine.
Trichlormethiazide
Hydralazine may increase the hypotensive activities of Trichlormethiazide.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Hydralazine.
UNOPROSTONE
Hydralazine may increase the hypotensive activities of Unoprostone.
Urapidil
Hydralazine may increase the hypotensive activities of Urapidil.
Valdecoxib
Valdecoxib may decrease the antihypertensive activities of Hydralazine.
Valsartan
Hydralazine may increase the hypotensive activities of Valsartan.
Vardenafil
Vardenafil may increase the antihypertensive activities of Hydralazine.
Verapamil
The risk or severity of adverse effects can be increased when Verapamil is combined with Hydralazine.
Vincamine
Hydralazine may increase the hypotensive activities of Vincamine.
Vinpocetine
Hydralazine may increase the hypotensive activities of Vinpocetine.
Xylometazoline
Hydralazine may increase the hypotensive activities of Xylometazoline.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Hydralazine.
Zileuton
Zileuton may decrease the antihypertensive activities of Hydralazine.
Zofenopril
Hydralazine may increase the hypotensive activities of Zofenopril.
Zomepirac
Zomepirac may decrease the antihypertensive activities of Hydralazine.
